Investor Relations News2020-08-20Sihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag IndustryPreviewPreviousSDIC leads the investment of Xuanzhu Biopharmaceutical with RMB 800 million, promoting innovation and R&DNextSihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag Industry
